STUDIES ON HINDERED PHENOLS AND ANALOGS .2. 1,3-BENZOXATHIOLES HAVING SRS-A INHIBITING ACTIVITY

被引:24
作者
AIZAWA, Y
KANAI, T
HASEGAWA, K
YAMAGUCHI, T
IIZUKA, Y
IWAOKA, T
YOSHIOKA, T
机构
[1] SANKYO CO LTD,MED CHEM RES LABS,2-58 HIROMACHI 1 CHOME,SHINAGAWA KU,TOKYO 140,JAPAN
[2] SANKYO CO LTD,NEW LEAD RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN
[3] SANKYO CO LTD,BIOL RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN
[4] SANKYO CO LTD,ANALYT & METAB RES LABS,TOKYO 140,JAPAN
关键词
D O I
10.1021/jm00167a032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of hindered phenolic 1,3-benzoxathioles (7a-1) were prepared and investigated for biological properties. Many compounds had LPO-lowering, antisuperoxide inhibiting, SRS-A inhibiting, and 5-lipoxygenase inhibiting activities. Among them, 5-hydroxy-4,6,7-trimethyl-2-propyl-l,3-benzoxathiole (7d) and 3-(5-hydroxy-4,6,7-tri-methyl-l,3-benzoxathiol-2-yl)propanol (7j) were most potent in SRS-A inhibiting and 5-lipoxygenase inhibiting activities, respectively, and were selected for further development as candidate drugs for the treatment of asthma. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:1491 / 1496
页数:6
相关论文
共 37 条
[1]  
ASAYAMA K, 1984, DIABETES, V3, P160
[2]  
CHAIT A, 1986, ATHEROSCLEROSIS, V7, P491
[3]   SYNTHESIS OF 5-HYDROXY-1,3-BENZOXATHIOLE [J].
DEGANI, I ;
DOLCI, M ;
FOCHI, R .
SYNTHETIC COMMUNICATIONS, 1980, 10 (02) :161-166
[4]  
FEARS R, 1984, DRUG TODAY, V20, P257
[5]  
HASEGAWA K, UNPUB
[6]   PHARMACOLOGICAL PROPERTIES OF A NEW ANTI-INFLAMMATORY COMPOUND, ALPHA-(3,5-DI-TERT-BUTYL-4-HYDROXYBENZYLIDENE)-GAMMA-BUTYROLACTONE (KME-4), AND ITS INHIBITORY EFFECTS ON PROSTAGLANDIN SYNTHETASE AND 5-LIPOXYGENASE [J].
HIDAKA, T ;
HOSOE, K ;
ARIKI, Y ;
TAKEO, K ;
YAMASHITA, T ;
KATSUMI, I ;
KONDO, H ;
YAMASHITA, K ;
WATANABE, K .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 (01) :77-85
[7]  
ISOMURA Y, 1984, CHEM PHARM BULL, V32, P152
[8]  
IWAOKA T, 1988, ROLE OXYGEN CHEM BIO, P461
[9]  
KATSUMI I, 1986, CHEM PHARM BULL, V34, P121
[10]  
LUNDBERG WO, 1962, AUTOOXIDATION ANTIOX, V2